Integrin Activity-Inhibitory Peptide FNIII 14 Increases the Chemosensitivity of Melanoma Cells to Anticancer Drugs and Suppresses Tumor Metastasis
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-03-01
著者
-
Fukai Fumio
Faculty Of Pharmaceutical Sciences Tokyo University Of Science
-
Fukai Fumio
Faculties Of Pharmaceutical Sciences Tokyo University Of Science
-
Saito Yohei
Faculty Of Pharmaceutical Science Tokyo University Of Sciences
-
TUKUDA Jiro
Faculty of Pharmaceutical Sciences, Tokyo University of Science
-
NAKANE Yoshitomi
Faculty of Pharmaceutical Sciences, Tokyo University of Science
-
Tukuda Jiro
Faculty Of Pharmaceutical Sciences Tokyo University Of Science
-
Nakane Yoshitomi
Faculty Of Pharmaceutical Sciences Tokyo University Of Science
-
Saito Yohei
Faculty of Pharmaceutical Sciences, Tokyo University of Science
関連論文
- S-8 フィブロネクチンおよびテネシン分子由来細胞接着調節性ペプチドによる細胞分化の制御
- Antiadhesive Sites Present in the Fibronectin TypeIII-Like Repeats of Human Plasma Fibronectin
- Antiadhesive Sites Present in the Fibronectin Type III-Like Repeats of Human Plasma Fibronectin(Molecular and Cell Biology)
- Synthesis and Properties of TN III Peptide Analogs Derived from Type III Repeat of Tenascin C
- Programmed Cell Death of Malignant Cell Types through Integrin Signal Activation
- Characterization of Active Sequence in the Integrin-Activating Peptide (TNIII) and Its Cell Surface Mediators
- Inhibition of Angiogenesis by a Tenascin-C Peptide which Is Capable of Activating Beta1-Integrins(Molecular and Cell Biology)
- Membrane Receptor Mediating the Antiadhesive Effect of Peptide FNIII14
- Suppression of Angiogenesis by the Integrin Function-Regulating Peptides
- Activation of Betal Integrins by the FNIII14 Analogous Peptide Induces Programmed Cell Death of Malignant Cell Types